Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma
US6248308A · kind A · utility
3Cited by
2References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 14, 1998 |
| Grant date | Jun 19, 2001 |
| Priority date | — |
| Expiry date | Apr 14, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions employing norastemizole and a leukotriene inhibitor for the treatment or prevention of inflammation or allergic disorders, such as asthma or the symptoms thereof. Also included are methods and compositions employing norastemizole and a decongestant for the treatment or prevention of inflammation or allergic disorders, such as asthma or the symptoms thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.